Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 164.56

-0.7%

10:37 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (242)	9/30/2000 9:11:27 PM
From: Scott H. Davis	Read Replies (2) of 395

David, Thanks. When I was at the third DAN! conference, one of the presenters showed both a far greater incidence of a flawed phenol-sulpherase (sp?) detoxification pathway in autism that in the general population & spoke of how this impaired ability to deal with heav metal toxins, the presence of mercury and/or aluminum in vaccines & the increasing number of vaccines at a progressively early age contributed to the increase in autism. But I missed the therapy potential of chelation. Scott

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next